TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Clinical Infectious Diseases
Research from H. Amagase and co-authors in the area of clinical infectious diseases published
April 1st, 2008
According to recent research published in the journal Clinical Infectious Diseases, "In Japan, probiotics are available as both foods and drugs. Unlike in the United States, probiotics have a long history of cultural acceptance and safe use in Japan." "Sales are booming, which may reflect the inception of the regulatory category ''foods for specialized health use'' (FOSHU), which permits labeling with claims that describe health benefits. A total of 65 probiotic products, containing 16 different strains, are listed among the 579 FOSHU products," wrote H. Amagase and colleagues. The researchers concluded: "Since the US market for probiotics is...
Source: TB & Outbreaks Week (2008-04-01)
|
